Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes
and results in patches of depigmentation that are visible as white spots. Recent research …

Vitiligo is a complex disease whose pathogenesis results from the interaction of genetic
components, metabolic factors linked to cellular oxidative stress, melanocyte adhesion to the …

Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …

Vitiligo is an autoimmune skin disease characterized by the targeted destruction of
melanocytes by T cells. Cytokine signaling between keratinocytes and T cells results in …

Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown,
which usually occurs with asymptomatic whitish patch or macule. Although several …

Vitiligo is an autoimmune cutaneous disease in which melanocytes are destroyed by CD8+
T cells resulting in disfiguring white spots. From the very beginning of the disease, oxidative …

Vitiligo is a multifactorial polygenic disorder with a complex pathogenesis, linked with both
genetic and non‐genetic factors. The precise modus operandi for vitiligo pathogenesis has …

Regulatory T cells (Tregs) are comprised of a heterogeneous population of cells that play a
vital role in suppressing inflammation and maintaining immune tolerance. Given the crucial …